nba ヤフー Group

Under the banners of "advanced technology," "clean environment," nba ヤフー "superior quality," Otsuka Techno molds nba ヤフー processes various types of resin, from commodity plastics to super engineering plastics.

As a specialist manufacturer of prefilled syringes, the company aims to constantly produce top-quality products with cutting-edge manufacturing equipment, stringent quality control, nba ヤフー continuous product improvements based on medical practice needs.

We will strive to contribute to the health of people around the world through a wide range of innovative nba ヤフー creative products, enteral nutrition formulas (prescription drugs), nba ヤフー iEat, a diet for people who have difficulty chewing, nba ヤフー aim to be a “nutrition care supporter” who can promptly provide more meaningful products nba ヤフー information.

The company contributes to urinary care in the super-aging society by developing devices which can visually indicate the urinary output in the bladder using ultrasound technology nba ヤフー by providing unique solutions.

We will work on the production nba ヤフー development of advanced medical devices utilizing innovative technologies such as a device for checking the position of the　nasogastric tube tip.

Suzhou Otsuka Pharmaceutical was established in February 2007 in Suzhou, a major center for Japanese corporations in China. Suzhou Industrial Park, where the company’s factory is located, has rich sources of water nba ヤフー is well known for its beautiful natural environment nba ヤフー favorable climate. Utilizing Japanese technology nba ヤフー equipment, a base of highly skilled nba ヤフー experienced employees manufacture high-quality antibiotics kits.

In 2013, Otsuka Pharmaceutical Factory made capital participation in a newly established IV business company with the aim of entering the IV sector in the promising Indian medical products market. In March 2017, the company name changed to Otsuka Pharmaceutical India Private Limited. Great efforts are being put into the creation of a fusion between respect for Indian culture nba ヤフー the Otsuka ethos, where mutual understnba ヤフーing with local staff is fostered nba ヤフー we all grow together.

Established in 1973 nba ヤフー a member of the Otsuka Group since 1995, PT Widatra Bhakti manufactures nba ヤフー distributes IV products in Indonesia. The company began exporting products to all parts of Asia in 2006, nba ヤフー construction of a new factory was completed in 2013 in anticipation of future market growth. The company has the top share of the Indonesian IV market.

Otsuka Pharmaceutical Vietnam JSC, originally established in 2003 as a joint venture, has its headquarters/factory in Dong Nai province in southern Vietnam, with offices in Ho Chi Minh nba ヤフー Hanoi. The company manufactures nba ヤフー sells IV solutions in plastic bottles nba ヤフー sells them domestically nba ヤフー internationally, nba ヤフー also imports nba ヤフー sells nutritional infusions nba ヤフー medical foods in Vietnam. The company works to contribute to the health nba ヤフー medical development of people not only in Vietnam but also in Southeast Asia.

Egypt Otsuka Pharmaceutical was established as a joint venture in 1993, as the successor to Arab Otsuka Pharmaceutical, which had been in operation since 1977. IV products are manufactured nba ヤフー distributed in Egypt nba ヤフー exported to nearby countries across Africa nba ヤフー the Middle East. We are proactive in expnba ヤフーing production lines nba ヤフー introducing new product lines- at present 30 million IV products are produced every year, with a share of just under 30% of the Egyptian IV market.

In 2014, Egypt Otsuka Pharmaceutical made an Egyptian manufacturing nba ヤフー distribution company of IV solutions a subsidiary with the aim of expnba ヤフーing its manufacturing capacity, nba ヤフー in later years it was renamed “Otsuka Al-Obour Pharmaceutical Egypt S.A.E.” This acquisition strengthened the manufacturing capacity of IV solutions in Egypt nba ヤフー sufficiently meets the increasing demnba ヤフー in the market. Otsuka Al-Obour Pharmaceutical Egypt S.A.E. will supply IV products of high quality to not only Egypt but also the Middle East nba ヤフー Africa.

In 2021, Egypt Otsuka Pharmaceutical Co., S.A.E. jointly invested with a local pharmaceutical company to establish Otsuka Gypto Pharmaceutical Egypt S.A.E. as a new company that sells IV solutions nba ヤフー other ethical drugs. Otsuka Gypto provides information on ethical drugs, including high-quality IV solutions manufactured by Egypt Otsuka Pharmaceutical nba ヤフー the local pharmaceutical company, nba ヤフー will sell the drugs not only in Egypt but also in neighboring countries such as the Middle East nba ヤフー Africa.

Established in 1974 as a joint venture, PT Otsuka Indonesia built a factory in Lawan, East Java, blessed with water resources, nba ヤフー started manufacturing nba ヤフー selling IV products. Starting with manufacturing nba ヤフー selling basic IV solutions, the company currently sells pharmaceuticals in the clinical nutrition field, ethical drugs, nba ヤフー medical devices. Moreover, as a leading company of IV solutions in Indonesia, the company not only develops its business domestically but also exports pharmaceuticals overseas, including to Australia, Singapore, nba ヤフー Sri Lanka.

In 2011, Diatranz Otsuka founded in New Zealnba ヤフー is　working on the development nba ヤフー commercialization of pancreatic islet “DIABECELL®” as a treatment for diabetes. In order to offer new treatment options to patients with diabetes, Diatranz Otsuka aims to commercialize DIABECELL as soon as possible. In addition, to promote the spread of xenotransplantation, we support the establishment of the safety nba ヤフー effectiveness of xenotransplantation.